PAVmed Inc. is a diversified commercial-stage medical technology company focused on developing and commercializing innovative products in the medical device, diagnostics, and digital health sectors. Its portfolio includes specialized tools designed to enhance patient care and clinical outcomes. Through its subsidiary Lucid Diagnostics Inc., PAVmed Inc. markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device, which enable the early detection of esophageal precancer to help prevent esophageal cancer. Veris Health Inc., another key subsidiary, specializes in digital health solutions for personalized cancer care, featuring implantable biologic sensors for remote patient monitoring, wireless communication, and a suite of connected external devices, alongside an implantable physiological monitor that integrates with the Veris Cancer Care Platform. PAVmed Inc. supports healthcare providers, clinicians, and patients by delivering technologies that address critical needs in oncology and beyond, operating a shared-services model to drive efficiency across its commercial activities.